Alyeska Investment Group’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Alyeska Investment Group’s Portfolio NARI Stock Details NARI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-327,145	Closed	-$19M	–	651
2023 Q2	$19M	Sell	327,145 -224,713	-41%	-$14.2M	0.14%	192
2023 Q1	$34.1M	Buy	+551,858	New	+$33.1M	0.3%	106
2021 Q3	–	Sell	-61,628	Closed	-$5.75M	–	817
2021 Q2	$5.75M	Buy	61,628 +13,108	+27%	+$1.27M	0.07%	313
2021 Q1	$5.19M	Sell	48,520 -1,870	-4%	-$194K	0.07%	313
2020 Q4	$4.4M	Buy	50,390 +42,098	+508%	+$2.97M	0.06%	296
2020 Q3	$572K	Sell	8,292 -23,229	-74%	-$1.49M	0.01%	413
2020 Q2	$1.53M	Buy	+31,521	New	+$1.51M	0.02%	373

Other funds holding NARI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Alyeska Investment Group's NARI Position: Q3 2023 in Review

Alyeska Investment Group sold out of Inari Medical, Inc. Common Stock (NARI) in Q3 2023, closing a stake of 327,145 shares — an estimated $19M sold.

Alyeska Investment Group first reported a position in NARI in Q2 2020 and held it in 7 quarters. The position peaked at $34.1M in Q1 2023. 250 funds tracked by Wall St. Rank hold NARI as of Q3 2023.

Alyeska Investment Group reported no remaining Inari Medical, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Alyeska Investment Group sold 327,145 Inari Medical, Inc. Common Stock shares in Q3 2023, an estimated $19M.
Alyeska Investment Group first reported a position in Inari Medical, Inc. Common Stock in Q2 2020 and held it in 7 quarters.
Alyeska Investment Group's Inari Medical, Inc. Common Stock position peaked at $34.1M in Q1 2023.
250 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q3 2023.

Based on Alyeska Investment Group's 13F filing for Q3 2023, filed 14 Nov 2023.